| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |